The Role of n-3 Polyunsaturated Fatty Acids in Human Heart Failure

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 13, Iss. 1, 2013-03 ,pp. : 105-117

Bentham Science Publishers

Access to resources Recommend Favorite

Chemoprevention of Lung Pathologies by Dietary n-3 Polyunsaturated Fatty Acids

By  

Current Medicinal Chemistry, Vol. 17, Iss. 29, 2010-10 ,pp. : 3358-3376

Bentham Science Publishers

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of n-3 Polyunsaturated Fatty Acids (PUFA) after Myocardial Infarction: Results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione Trial

By Franzosi M.G.  

PharmacoEconomics, Vol. 19, Iss. 4, 2001-04 ,pp. : 411-420

Adis International

Access to resources Recommend Favorite

N-3 (Omega-3) Polyunsaturated Fatty Acids in the Pathophysiology and Treatment of Depression: Pre-Clinical Evidence

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 4, 2013-06 ,pp. : 450-459

Bentham Science Publishers

Access to resources Recommend Favorite

G-Protein Signaling, Lipid Rafts and the Possible Sites of Action for the Antidepressant Effects of n-3 Polyunsaturated Fatty Acids

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 4, 2013-06 ,pp. : 466-473

Bentham Science Publishers

Access to resources Recommend Favorite